Parnell Pharmaceuticals Holdings Operating Income 2014-2018 | PARNF

Parnell Pharmaceuticals Holdings operating income from 2014 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Parnell Pharmaceuticals Holdings Operating Income 2014-2018 | PARNF

Parnell Pharmaceuticals Holdings operating income from 2014 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M